Company Quick10K Filing
Medixall Group
10-K 2020-12-31 Filed 2021-06-17
10-Q 2020-09-30 Filed 2020-11-17
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-06-16
10-K 2019-12-31 Filed 2020-05-14
S-1 2019-11-05 Public Filing
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-02
10-Q 2019-03-31 Filed 2019-05-30
10-K 2018-12-31 Filed 2019-05-16
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-06-29
10-K 2017-12-31 Filed 2018-03-01
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-22
10-K 2016-12-31 Filed 2017-03-30
10-Q 2016-09-30 Filed 2016-11-04
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-04-28
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-04-30
10-Q 2014-09-30 Filed 2014-12-01
8-K 2020-07-27
8-K 2020-06-24
8-K 2020-05-14
8-K 2018-06-01
8-K 2018-05-09
8-K 2018-03-07

Medixall Group Financials

MDXL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash0710000011531025620518730219202605151
Accounts Receivable
Inventory
PP&E1017171615181721
Assets072625252500115310334316404657441729882616559
Accounts Payable227212314663586887
Long-Term Debt
Liabilities1,0451,1419239841,0271,0881,1271,1801,021899808551481285488186351363362
Stockholders' Equity-1,044-1,134-897-959-1,002-1,063-1,127-1,180-906-589-474-235-77372-47543531253197
Income Statement ($'000)2014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue000000000010010011
Cost of Revenue000
Gross Profit000
R&D
SG&A
Tax00000000000000000
Net Income-90-108-128-22-60-40-52-505-389-376-344-1,012-616-735-744-670-715
Cash Flow ($'000)2014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating718-0-00-00-666-510-467-604-695-238-740-401-628
Cash Investing0000000-78-42-55-152-90-5
Cash Financing000000705491